IFNGR1 and Anxiety: Simultaneously inhibiting Casp1, Ifngr and Nos2 may result in a complex neuro-behavioural phenotype, different from individual gene knockouts, which decreases anxiety- and depressive-like behaviours at baseline, while preventing the exacerbation of anhedonic- but not of depressive- or anxiety-like behaviours following chronic stress exposure.